Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia

Key Points SEER data and a Bronx validation cohort demonstrate that Hispanics present with AML at younger age but have shorter survival than whites. Increased frequency of high-risk mutations in Hispanics provides a potential biologic explanation for poorer outcomes in Hispanics.